Ceritinib is a tyrosine kinase inhibitor that selectively and potently inhibits anaplastic lymphoma kinase (ALK). In regular physiology, ALK functions as being a critical phase in the event and performance of anxious method tissue. On the other hand, chromosomal translocation and fusion give increase to an oncogenic form of ALK https://genistein46802.bloggip.com/31345990/not-known-factual-statements-about-lovastatin